Navigation Links
Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer
Date:3/11/2010

luate efficacy and safety.  Overall, testosterone suppression with this new 45-mg six-month depot formulation was sustained in patients throughout the treatment period.  The onset of testosterone suppression was consistent with other currently available Lupron Depot formulations.

About Prostate Cancer

This year in the U.S., approximately 200,000 new cases of prostate cancer will be diagnosed.  Prostate cancer is the most common type of cancer diagnosed in American men.  More than 70 percent of all prostate cancers are diagnosed in men older than 65, and one in six men will be diagnosed with prostate cancer in their lifetime.

For additional information on Lupron Depot for the palliative treatment of advanced prostate cancer, visit www.prostate.com.

Full Prescribing Information for Lupron Depot 7.5 mg is available at


'/>"/>
SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Jaffray Healthcare Conference in New York ... PDT . Dr. Helen Torley , President and ... The presentation will be webcast through the "Investors" section of ... will be made available for 90 days following the event. ...
(Date:11/24/2014)... 2014  CryoLife, Inc. (NYSE: CRY ), a ... and vascular surgery, announced today that it will participate in ... on Wednesday, December 3, 2014 at The New York Palace ... A live webcast of the Company,s presentation is scheduled ... overview of the company by Pat Mackin , President ...
(Date:11/24/2014)... MONTREAL , Nov. 24, 2014 /PRNewswire/ - Milestone ... clinical trial conducted in Melbourne, Australia ... antagonist for the potential treatment of paroxysmal supraventricular ... formulation of MSP-2017 was well tolerated at single ... an excellent safety profile, desirable PK properties including ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... , , ... (Nasdaq: IPCM ), a leading national hospitalist physician group practice ... was named by ACP Hospitalist as one of the ... the November 2009 issue of the magazine. , Dr. Vaidyan has ...
... VIEW, Calif., Nov. 24 Satellite Healthcare, one of the ... a major sponsor of nephrology research, today announced its full ... his effort to support the San Jose homeless this Thanksgiving ... chef for the past 20 years. But Nasrallah,s life was ...
Cached Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... Vultures have developed highly specialized ways of dealing with ... researchers report. The new research investigated the different ... the guts of 50 turkey vultures and black vultures ... the vultures had more than 500 different types of ... found. The findings suggest that a vulture,s digestive ...
(Date:11/26/2014)... to peanut protein in household dust may increase the ... condition eczema, a new study reveals. About 2 ... allergic to peanuts. And severe eczema in infants has ... researchers noted. The new study included 359 infants ... the amount of peanut protein the children were exposed ...
(Date:11/26/2014)... News) -- Parents need to take an active role ... warns. Parents must make sure sports-playing teens have ... Dodick, chair of the American Migraine Foundation and a ... Medicine in Scottsdale, Ariz. in an American Migraine Foundation, ... coach involved with teens sports needs to have appropriate ...
(Date:11/24/2014)... 24, 2014 The Healthy Skin Care ... of affordable skin care products, recently announced its launch. ... readers a wide variety of articles, tips, and evaluations ... organic skincare alternatives. , According to Emily Lataille, the ... content includes thoroughly researched reviews, tips for the skin, ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2
... , BETHESDA, Md., Nov. 16 GetWellNetwork, Inc. ... chief operating officer. Ms. Perry, an experienced high-tech leader and ... level of growth and deliver on the promise of improving ... Among her priorities, Ms. Perry will focus on GetWellNetwork,s leadership ...
... extended-release niacin, or Niaspan , SUNDAY, Nov. 15 (HealthDay ... ezetimibe (Zetia), a drug used by millions of Americans ... cholesterol. , The trial, known as ARBITER-6 HALTS, was ... LDL-cholesterol-lowering Zetia was less effective than extended-release niacin (Niaspan), ...
... 16 Blue Water Spa, a Raleigh NC Day Spa and ... party and Raleigh food drive. Guests who donate frozen turkeys or ... receive a $10,000 spa gift certificate for luxury spa services. , ... on hand Wed. November 18 and Saturday December 12 to accept ...
... YORK, Nov. 16 Nearly every household has some sort of ... like. But how many people plan ahead for dental emergencies? ... leading provider of oral care products, although one in six Americans ... not prepared to deal with the problem. , "You keep ...
... ... researchers with online cognitive rehab tools for cognitive impairments caused by Alzheimer,s disease, Traumatic ... ... HAPPYneuron PRO, a suite of online cognitive rehab tools for a variety ...
... ... Socks for Kids who Wear Ankle-Foot Orthoses (AFOs) , ... Westchester, NY (PRWEB) November 16, 2009 -- Ross Daniel Adaptive ... marketplace debut and the launch of “Cool Clothes for Toes,” the first creatively styled sock ...
Cached Medicine News:Health News:GetWellNetwork Taps High-Tech Veteran Michele Perry as Chief Operating Officer 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 3Health News:Raleigh Day Spa, Blue Water Spa, Raffles Off $10,000 in Day Spa Packages for Contributing to Raleigh Food Drive 2Health News:Be Prepared for a Dental Emergency During the Holidays 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 3Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 2Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 3
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... The PowerLab/4SP is a high-performance data acquisition ... research applications including human and animal physiology, ... engineering. The unit is capable of recording ... (up to 200 000 samples per second ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: